Role of Autophagy in Maladaptive Renal Repair Following Acute Kidney Injury
Role of Autophagy in Maladaptive Renal Repair Following Acute Kidney Injury
批准号:
9355626
负责人:
FANGMING LIN
金额:
$24.0万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-21 至 2019-08-31
关键词:
Acute Renal Failure with Renal Papillary NecrosisAddressAdenovirusesAffectAtrophicAutophagocytosisBiochemical GeneticsBlood VesselsBlood capillariesCatabolismCellsChimeric ProteinsChronic Kidney FailureDegradation PathwayDevelopmentDigestionDisease ProgressionDown-RegulationDoxycyclineDropoutEnzymesEpithelialEpithelial CellsFOXO3A geneFRAP1 geneFeedbackFibrosisFutureGeneticGoalsHealthHydroxylationHypoxiaKidneyKidney DiseasesKidney FailureLeadLinkMaintenanceMediatingMetabolicMolecularMonitorMusNutrientOrganellesOxygenPathogenesisPathway interactionsPharmacologyPhasePrimary InfectionProcessReactionRegulationRenal tubule structureReperfusion InjuryReporterRoleStarvationStressSystemTestingTetanus Helper PeptideTissuesTranscriptional ActivationTransgenic OrganismsTubular formationVascular Endothelial Growth FactorsVirulence Factorsalpha ketoglutaratebiological adaptation to stresscapillarydensitydesignexperimental studygene repressiongenetic approachinjuredinterstitialnoveloverexpressionpreventrepairedresponsetooltranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Maladaptive renal repair following acute kidney injury (AKI) can lead to chronic kidney disease
(CKD) causing tubular atrophy, capillary rarefaction, and interstitial fibrosis. Hypoxia is a known
pathogenic factor in the development of CKD and can trigger autophagy, a lysosomal degradation
pathway that recycles intracellular constituents for energy reutilization. We have showed that
protracted metabolic perturbation in the injured kidney leads to a prolonged autophagic response and
contributes to tubular atrophy and vascular dropout. We now propose to extend these findings by
performing studies in the following aims. Aim 1 will examine metabolic perturbation and tubular
epithelial autophagy during the development of CKD resulting from ischemia-reperfusion injury (IRI).
We will use our novel autophagy reporter mice to quantify autophagy levels and monitor the
autophagic process in relationship with metabolic perturbation. Mice will be treated with a precursor of
acetyl co-enzyme A to directly test whether replenishing metabolites prevents tubular autophagy.
Next, we will test whether sustained epithelial autophagy can lead to tubular atrophy by taking genetic
and pharmacological approaches to alter autophagy levels and examine their effects on tubular
atrophy. In Aim 2, we will study molecular regulation of autophagy by FoxO3a and further explore our
newly discovered mechanism that links hypoxia to autophagy via activation of FoxO3a through
inhibition of prolyl hydroxylation and degradation of FoxO3a. We find that the stress-responsive
transcription factor FoxO3a is activated in renal tubules of the kidney with maladaptive repair.
Infection of primary cultures of renal epithelial cells with adenoviruses expressing constitutively
activated FoxO3a results in activation of the autophagic pathway. The effect and regulation of
sustained autophagy by FoxO3a in the diseased kidney will be investigated by performing deletion,
overexpression, and rescue experiments. Biochemical and genetic approaches will be applied to
understand FoxO3a prolyl hydroxylation via a PHD-mediated reaction that requires oxygen and α-
ketoglutarate. In Aim 3, we will test the hypothesis that tubules with sustained autophagy have
reduced Vefga expression, which contributes to capillary rarefaction. Vascular dropout creates further
metabolic perturbation to tubules, thus setting up a self-perpetuating, vicious cycle. We will delete
Vegfa specifically in renal tubules using a doxycycline-inducible system and examine the
interdependence of tubules and peritubular capillaries. Furthermore, we will study whether down-
regulation of tubule-derived Vegf is a result of general catabolic consequence from prolonged
autophagy and/or due to transcriptional repression by FoxO3a. The goals of this project are two-fold.
The first goal is to understand the pathogenesis during the transition from AKI to CKD by focusing on
tubular autophagy in the kidneys with metabolic disturbance. The second goal is to understand the
molecular regulation of epithelial autophagy by investigating hypoxia-induced FoxO3a activation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Generation of New Mouse Models of Low Nephron Numbers to Understand Pathogenesis of AKI and CKD in Humans Born Preterm
-
批准号:10066348
-
项目类别:
-
资助金额:$42.43万
-
财政年份:2019
-
负责人:FANGMING LIN
-
依托单位:
Generation of New Mouse Models of Low Nephron Numbers to Understand Pathogenesis of AKI and CKD in Humans Born Preterm
-
批准号:10310432
-
项目类别:
-
资助金额:$42.43万
-
财政年份:2019
-
负责人:FANGMING LIN
-
依托单位:
STEM CELL THERAPY FOR ACUTE KIDNEY INJURY
-
批准号:8334695
-
项目类别:
-
资助金额:$27.44万
-
财政年份:2009
-
负责人:FANGMING LIN
-
依托单位:
STEM CELL THERAPY FOR ACUTE KIDNEY INJURY
-
批准号:8539674
-
项目类别:
-
资助金额:$26.48万
-
财政年份:2009
-
负责人:FANGMING LIN
-
依托单位:
STEM CELL THERAPY FOR ACUTE KIDNEY INJURY
-
批准号:8254902
-
项目类别:
-
资助金额:$17.21万
-
财政年份:2009
-
负责人:FANGMING LIN
-
依托单位:
STEM CELL THERAPY FOR ACUTE KIDNEY INJURY
-
批准号:8135545
-
项目类别:
-
资助金额:$27.44万
-
财政年份:2009
-
负责人:FANGMING LIN
-
依托单位:
Use of Umbilical Core Blood derived HSC to Treat Acute Kidney Injury
-
批准号:7936898
-
项目类别:
-
资助金额:$30.72万
-
财政年份:2009
-
负责人:FANGMING LIN
-
依托单位:
STEM CELL THERAPY FOR ACUTE KIDNEY INJURY
-
批准号:8583988
-
项目类别:
-
资助金额:$0.15万
-
财政年份:2009
-
负责人:FANGMING LIN
-
依托单位:
STEM CELL THERAPY FOR ACUTE KIDNEY INJURY
-
批准号:7741820
-
项目类别:
-
资助金额:$37.68万
-
财政年份:2009
-
负责人:FANGMING LIN
-
依托单位:
Use of Umbilical Core Blood derived HSC to Treat Acute Kidney Injury
-
批准号:7832028
-
项目类别:
-
资助金额:$29.83万
-
财政年份:2009
-
负责人:FANGMING LIN
-
依托单位:
STEM CELL THERAPY FOR ACUTE KIDNEY INJURY
-
批准号:7921597
-
项目类别:
-
资助金额:$20.1万
-
财政年份:2009
-
负责人:FANGMING LIN
-
依托单位:
STEM CELL THERAPY IN ACUTE RENAL FAILURE
-
批准号:7059864
-
项目类别:
-
资助金额:$12.42万
-
财政年份:2003
-
负责人:FANGMING LIN
-
依托单位:
STEM CELL THERAPY IN ACUTE RENAL FAILURE
-
批准号:6558460
-
项目类别:
-
资助金额:$12.42万
-
财政年份:2003
-
负责人:FANGMING LIN
-
依托单位:
STEM CELL THERAPY IN ACUTE RENAL FAILURE
-
批准号:6744319
-
项目类别:
-
资助金额:$12.42万
-
财政年份:2003
-
负责人:FANGMING LIN
-
依托单位:
STEM CELL THERAPY IN ACUTE RENAL FAILURE
-
批准号:7231013
-
项目类别:
-
资助金额:$12.42万
-
财政年份:2003
-
负责人:FANGMING LIN
-
依托单位:
STEM CELL THERAPY IN ACUTE RENAL FAILURE
-
批准号:6893318
-
项目类别:
-
资助金额:$12.42万
-
财政年份:2003
-
负责人:FANGMING LIN
-
依托单位:
海外基金